arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 3/2015 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Propranolol (HEMANGIOL) for infantile hemangioma

    GLP-1 receptor agonist dulaglutide (TRULICITY) for type 2 diabetes

    VIEKIRAX plus dasabuvir (EXVIERA) - multiple combination therapy against hepatitis C

    THERAPY FROM A CRITICAL VIEWPOINT

    GRAZAX and ORALAIR: sublingual immunotherapy for grass pollen allergy

    BEWARE MISINFORMATION

    Emergency contraception: scientific associations' criticism about non-prescription status is baseless

    CURRENT ADR NETWORK REPORT

    Liver damage due to IBEROGAST?
    free

    SIDE EFFECTS

    EMA, FDA: cardiovascular safety of testosterone (e.g. NEBIDO) not established

    e a-t IN INTERNET

    Varenicline (CHAMPIX): decreased tolerance to alcohol, seizures etc.

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles